Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nitto Denko Corporation (6988.T)
Osaka, JP
Nitto Denko Corporation, established in 1918 and headquartered in Osaka, Japan, operates as a global enterprise with a primary focus on adhesive tapes. Its extensive product portfolio caters to a wide array of industries internationally. Offerings include various adhesive solutions like double-sided, masking, and packaging tapes, along with specialized tapes for electrical and electronic applications. The company also manufactures surface protective films, sealing materials (including NVH-related products), membranes, gasket materials, and critical components for advanced technology such as FPD/touch panel products, semiconductor manufacturing process materials, and flexible printed circuit boards. Additionally, they provide porous and breathable films, fluoroplastic sheets and films, and materials for housing and construction. Complementing these products are functional thermal transfer systems—encompassing labels, barcode printers, and software—as well as dust removal items for clean rooms and packaging machinery. In the medical field, Nitto Denko develops transdermal therapeutic systems, athletic tapes, specialized medical adhesive tapes for wearables and biosensors, and particles used in nucleic acid synthesis. These diverse products serve sectors including automotive, transportation, housing, infrastructure, materials, home appliances, electrical goods, display technology, electronic devices, healthcare, packaging, and consumer/personal care.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.00% | -4.27% | -0.23% | -17.78% | -22.55% | -19.67% | +13.04% | +46.31% | +76.12% | +109.42% | +382.34% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 5 | 0 |
| Hold | 4 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +7.2%+10.8% ★ Q1'26: +2.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +16.5%+36.0% ★ Q1'26: +1.1% (vs Q1'25)
-
FCF margin Chemicals - Specialty: +27.4%+13.3% Q1'26: +15.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +9.5%+19.4% ★ Q1'26: +15.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +6.2%+19.9% ★ Q1'26: +14.1% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.0%-1.7% ★ Q1'26: -3.7% (vs Q1'25)
-
Debt / EBITDA Chemicals - Specialty: 0.21×0.12× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 12 Rev. Ana. 12 EPS Ana. |
Mar 2027 10 Rev. Ana. 10 EPS Ana. |
Mar 2028 12 Rev. Ana. 12 EPS Ana. |
Mar 2029 7 Rev. Ana. 7 EPS Ana. |
Mar 2030 3 Rev. Ana. 2 EPS Ana. |
Mar 2031 5 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
825.24B
est: 828.91B (-0.4%)
|
793.05B
est: 805.00B (-1.5%)
|
767.71B
est: 752.38B (+2.0%)
|
856.26B
est: 862.37B (-0.7%)
|
806.50B
est: 809.38B (-0.4%)
|
741.02B
est: 738.17B (+0.4%)
|
761.32B
est: 756.71B (+0.6%)
|
853.45B
est: 849.34B (+0.5%)
|
929.04B
est: 941.82B (-1.4%)
|
915.14B
est: 955.99B (-4.3%)
|
1.01T
est: 1.01T (+0.8%)
|
1.03T
1.00T – 1.05T
+2.5% YoY
|
1.06T
1.04T – 1.08T
+2.5% YoY
|
1.09T
1.07T – 1.14T
+3.6% YoY
|
1.14T
1.14T – 1.14T
+4.3% YoY
|
1.17T
1.14T – 1.20T
+2.2% YoY
|
1.20T
1.18T – 1.24T
+2.8% YoY
|
| EBITDA |
146.45B
est: 181.26B (-19.2%)
|
143.74B
est: 176.03B (-18.3%)
|
148.29B
est: 164.52B (-9.9%)
|
181.00B
est: 188.57B (-4.0%)
|
135.23B
est: 176.99B (-23.6%)
|
126.19B
est: 161.41B (-21.8%)
|
148.42B
est: 165.47B (-10.3%)
|
185.70B
est: 185.72B (0.0%)
|
209.20B
est: 205.95B (+1.6%)
|
202.04B
est: 283.91B (-28.8%)
|
262.50B
est: 298.64B (-12.1%)
|
305.99B
297.99B – 311.15B
+2.5% YoY
|
313.55B
308.18B – 320.16B
+2.5% YoY
|
324.94B
318.44B – 338.51B
+3.6% YoY
|
338.77B
337.99B – 339.54B
+4.3% YoY
|
346.31B
339.87B – 357.26B
+2.2% YoY
|
355.93B
349.32B – 367.19B
+2.8% YoY
|
| EBIT |
100.79B
est: 129.08B (-21.9%)
|
95.21B
est: 125.36B (-24.1%)
|
99.73B
est: 117.17B (-14.9%)
|
131.72B
est: 134.29B (-1.9%)
|
89.32B
est: 126.04B (-29.1%)
|
76.80B
est: 114.95B (-33.2%)
|
100.47B
est: 117.84B (-14.7%)
|
135.49B
est: 132.27B (+2.4%)
|
151.83B
est: 146.67B (+3.5%)
|
141.23B
est: 208.45B (-32.2%)
|
196.91B
est: 219.27B (-10.2%)
|
224.66B
218.79B – 228.45B
+2.5% YoY
|
230.21B
226.27B – 235.06B
+2.5% YoY
|
238.58B
233.81B – 248.54B
+3.6% YoY
|
248.73B
248.16B – 249.30B
+4.3% YoY
|
254.27B
249.54B – 262.31B
+2.2% YoY
|
261.33B
256.47B – 269.59B
+2.8% YoY
|
| Net Income |
77.88B
est: 61.71B (+26.2%)
|
81.68B
est: 70.32B (+16.2%)
|
63.45B
est: 52.84B (+20.1%)
|
87.38B
est: 83.44B (+4.7%)
|
66.56B
est: 62.13B (+7.1%)
|
47.16B
est: 44.38B (+6.3%)
|
70.24B
est: 62.11B (+13.1%)
|
97.13B
est: 89.06B (+9.1%)
|
109.17B
est: 98.51B (+10.8%)
|
102.68B
est: 119.04B (-13.7%)
|
137.24B
est: 132.41B (+3.6%)
|
133.50B
126.21B – 142.86B
+0.8% YoY
|
141.25B
136.26B – 146.75B
+5.8% YoY
|
152.37B
145.76B – 168.76B
+7.9% YoY
|
158.27B
156.99B – 167.42B
+3.9% YoY
|
167.95B
163.89B – 174.86B
+6.1% YoY
|
178.38B
174.07B – 185.71B
+6.2% YoY
|
| SGA |
106.41B
est: 125.89B (-15.5%)
|
106.54B
est: 122.26B (-12.9%)
|
109.02B
est: 114.27B (-4.6%)
|
118.42B
est: 130.97B (-9.6%)
|
120.58B
est: 122.92B (-1.9%)
|
111.37B
est: 112.11B (-0.7%)
|
107.72B
est: 114.92B (-6.3%)
|
129.63B
est: 128.99B (+0.5%)
|
145.44B
est: 143.04B (+1.7%)
|
146.14B
est: 147.21B (-0.7%)
|
151.84B
est: 154.85B (-1.9%)
|
158.66B
154.51B – 161.33B
+2.5% YoY
|
162.57B
159.79B – 166.00B
+2.5% YoY
|
168.48B
165.11B – 175.52B
+3.6% YoY
|
175.65B
175.25B – 176.05B
+4.3% YoY
|
179.56B
176.22B – 185.24B
+2.2% YoY
|
184.55B
181.12B – 190.39B
+2.8% YoY
|
| EPS |
94.35
est: 87.86 (+7.4%)
|
99.05
est: 100.11 (-1.1%)
|
78.19
est: 75.22 (+3.9%)
|
107.80
est: 118.79 (-9.3%)
|
84.70
est: 88.45 (-4.2%)
|
60.26
est: 63.18 (-4.6%)
|
94.54
est: 88.43 (+6.9%)
|
131.26
est: 126.80 (+3.5%)
|
147.75
est: 140.25 (+5.3%)
|
143.91
est: 174.30 (-17.4%)
|
195.74
est: 192.47 (+1.7%)
|
199.06
186.36 – 210.94
+3.4% YoY
|
208.27
201.20 – 216.69
+4.6% YoY
|
225.00
215.23 – 249.19
+8.0% YoY
|
239.46
231.81 – 247.22
+6.4% YoY
|
248.00
242.01 – 258.19
+3.6% YoY
|
263.40
257.04 – 274.23
+6.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-14 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-13 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-10 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hideo Takasaki | CEO & Chairperson | 271M | male |
| Yasuhiro Iseyama | Senior EVP, CFO, GM of Corporate Accounting, Finance Division & Export Control Center and Director | 128M | male |
| Yasuhito Ohwaki | Senior EVP, CHRO, GM of Corporate Human Resources Division & Director | 128M | male |
| Yosuke Miki | Senior EVP, CTO, GM of Corporate Technology Sector & Director | 128M | male |
| Tatsuya Akagi | President, COO & Representative Director | 94M | male |
| Nobuyuki Aoki | Senior Vice President | — | — |
| Norio Sato | Senior Vice President & GM of Advanced Film Solution Division | — | — |
| Seiji Fujioka | Executive Vice President. GM of South Asia, India, & Oceania Rep Direc, Nitto Denko (Singapore) Pte.Ltd. | — | male |
| Yasuhiro Hayashi | Senior Vice President and GM of Legal & Compliance Division | — | — |
| Atsushi Ukon | Senior Vice President | — | male |
| Yukihiro Horikawa | Executive VP. GM of Human Life Solutions Sector and GM of North America & South America | — | — |
| Bae-Won Lee | Senior Vice President & GM of South Korea | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6988.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
